Genopathy
Gene-Disorder Association · Article
Gene
TUBA4B
Tubulin Alpha 4b
Disorder
Breast Cancer
First reported 1950
Supporting publications 1
Approved treatment annotated
Association Review

In brief

The association between TUBA4B (Tubulin Alpha 4b) and Breast Cancer is reported, supported by a single source.

Sources 1
Clinical variants 0
Symptoms 4
Compounds 1
Trials 798of 3,366 via TUBA4B compounds
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
TUBA4B

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Breast Cancer

The disorder

23 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

3,366 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

8 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access